4//SEC Filing
Baumal Caroline 4
Accession 0001127602-25-001612
CIK 0001492422other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 3:54 PM ET
Size
6.2 KB
Accession
0001127602-25-001612
Insider Transaction Report
Form 4
Baumal Caroline
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-01-17$29.96/sh−1,853$55,513→ 53,707.37 total - Award
Common Stock
2025-01-21+39,594→ 93,301.37 total
Footnotes (2)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 16, 2025.
- [F2]This represents a Restricted Stock Unit award granted on January 21, 2025 that vest 25% annually over four years from grant date subject to continued service.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001961100
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 3:54 PM ET
- Size
- 6.2 KB